Sentences with phrase «by antibiotic resistant»

Genetically modified foods pose a negligible risk of increasing infectious diseases caused by antibiotic resistant bacteria.
There is an urgent need for new antibiotics capable of treating infections caused by antibiotic resistant bacteria.»

Not exact matches

The drug targets a wider variety of defence mechanisms used by antibiotic - resistant bacteria and can be used in more situations.
One approach used by Cubist is to target the enzymes produced by drug - resistant bacteria that degrade antibiotic agents and render them useless.
This steady stream of antibiotics contributes to the development of antibiotic - resistant bacteria and superbugs that can not be killed by standard antibiotics.
This makes me happy: Research on ribosomes by Noller and others has led to the development of novel antibiotics that hold promise for use against drug - resistant bacteria.
Dangerous resistant bacteria tend to develop spontaneously in the bodies of patients being given powerful antibiotics for long periods, and virtually never by accident in the laboratory or in the field.
This steady stream of antibiotics contributes to the development of antibiotic - resistant bacteria and superbugs that can not be killed by standard antibiotics.
Recently, medicine has been confronted by a surging number of antibiotic resistant bacteria.
It's all a vicious cycle: use chemicals, create resistant bacteria, get sick, take antibiotics, wipe out the good bacteria, get attacked again by even worse bacteria...
Today's publication of «Tackling Drug Resistant Infections Globally: Final Report and Recommendations», by Lord Jim O'Neill, is a global landmark in the fight to keep antibiotics effective for both animals and people, says NOAH, which represents the UK animal medicines sector.
By most metrics the antibiotic - resistant and susceptible strains of Staphylococcus epidermidis are phenotypically identical, and thus present a major challenge to traditional analytical separation techniques.
The discovery might lead to better ways to fight a class of bacteria that have contributed to a growing public health crisis by becoming increasingly resistant to antibiotic treatments.
Earlier this year the same panel — chaired by economist Jim O'Neill, formerly of investment bank Goldman Sachs — reported that companies aren't developing new antibiotics fast enough to keep up with the rate at which bacteria are becoming resistant to existing ones.
«We also need to develop delivery systems to deploy the treatment in a variety of settings that are currently affected by antibiotic - resistant bacteria.»
That's good news because many of the most dangerous pathogens that are resistant to antibiotics are gram - negative (SN: 6/10/17, p. 8), according to a list released by the WHO in February.
A new broad range antibiotic, developed jointly by scientists at The Rockefeller University and Astex Pharmaceuticals, has been found to kill a wide range of bacteria, including drug - resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs.
Infected Infections Page 20, by Linda Marsa A new weapon against antibiotic - resistant bacteria could be here to stay.
A recent study from a U.K. commission on antimicrobial resistance estimated that by 2050, antibiotic - resistant bacterial infections will kill 10 million people per year, if no new drugs are developed.
For the first time, scientists have shown that MRSA (methicillin - resistant Staphylococcus aureus) and other antibiotic - resistant «superbug» infections can be tracked across Europe by combining whole - genome sequencing with a web - based system.
The antibiotic, first identified by Nosopharm, is unique and promising on two fronts: its unconventional source and its distinct way of killing bacteria, both of which suggest the compound may be effective at treating drug - resistant or hard - to - treat bacterial infections.
The findings, announced online in the journal Antimicrobial Agents and Chemotherapy and funded by the National Institutes of Health, provide a needed boost to the field of antibiotic development, which has been limited in the last four decades and outpaced by the rise of drug - resistant bacterial strains.
A study by scientists at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health finds New York City house mice carry bacteria responsible for mild to life - threatening gastroenteritis in people, and some of these bacteria may be resistant to antibiotics.
The paper, by three researchers at the University of Vermont, uses a series of time - lapse videos to show that single cells within a community of bacteria randomly use a cascade of proteins to become more or less antibiotic resistant, even when the community is not threatened by an antibiotic.
The work is part of a global response to the need to reduce the use of antibiotics, driven in part by President Obama's National Action Plan for Combating Antibiotic - Resistant Bacteria.
A 2014 review of antimicrobial resistance reported that unless something is done to stop the evolution of antibiotic - resistant bacteria, such so - called superbugs could cost the world $ 100 trillion in gross - domestic - product losses by 2050.
The top risk for both humans and animals was E.coli and in humans this was followed by two forms of HIV, Hepatitis C and Staphylococcus aureus, a bacteria which causes food poisoning and is increasingly resistant to antibiotics.
The infections have been linked to medical scopes believed to have been contaminated with bacteria that can resist carbapenems, potent antibiotics that are supposed to be used only in gravely ill patients or those infected by resistant bacteria.
«They've done this by altering their genetic make - up; transferring drug - resistant genes between one another; and creating biofilms, which are multicellular communities where bacteria can be a thousand-fold more resistant to antibiotics
The illustration, based on electron micrographs and created by the Centers for Disease Control and Prevention, shows one of these antibiotic - resistant bacteria.
In addition to TDA's killing mechanism, the researchers were interested in understanding the mechanism by which a bacterial strain could become resistant to the antibiotic.
The investigators also found that young people with antibiotic - resistant infections stayed in the hospital 20 percent longer than those whose infections could be addressed by antibiotics.
Two days later, the lab results came back, revealing that Gehrke did not have E. coli, but rather a staphylococcus, or staph, infection caused by methicillin - resistant Staphylococcus aureus (MRSA), a potent bacterium that has developed resistance to most of the old standby antibiotics, making it difficult to treat and potentially fatal.
In a new, first - of - its - kind study, researchers from Case Western Reserve University School of Medicine have found a 700 - percent surge in infections caused by bacteria from the Enterobacteriaceae family resistant to multiple kinds of antibiotics among children in the US.
After only a few hours surrounded by Pseudomonas, Staph became antibiotic - resistant.
Cow dung encourages antibiotic - resistant bacteria to grow, even if it comes from drug - free cows, according to a study by Jo Handelsman, associate director for science at the White House Office of Science and Technology Policy.
Biologists traditionally accomplish this feat by pairing up the desired gene, or transgene, with another gene that makes the cell resistant to antibiotics.
A landmark genomic study, with contributors from over two - dozen countries, shows the current problem of antibiotic resistant typhoid is driven by a single clade, family of typhoid bacteria, called H58 that has now spread globally.
At the Veterans Affairs Medical Center in Minneapolis, when the antibiotic gentamicin was no longer given for infections by a variety of resistant gut bacteria, including E. coli, the levels of resistance dropped accordingly.
Bacteria can become resistant to the antibiotic either as the result of a spontaneous mutation or by picking up an appropriate «resistance gene» (which codes for a protein that confers resistance) from another bacterium via genetic exchange.
Last month, Lu's lab reported a different approach to combating resistant bacteria by identifying combinations of genes that work together to make bacteria more susceptible to antibiotics.
The breakthrough is another major step forward on the journey to develop a commercially viable drug version based on teixobactin — a natural antibiotic discovered by US scientists in soil samples in 2015 which has been heralded as a «gamechanger» in the battle against antibiotic resistant pathogens such as MRSA and VRE.
To explore the health consequences of bacterial quorum sensing in the crypts, the researchers experimented with an antagonist to turn off quorum sensing in chambers colonized by methicillin - resistant S. aureus (MRSA), an antibiotic - resistant strain of bacteria that causes human infection.
By some estimates, more than 75 percent of poultry is contaminated with E. coli, much of it resistant to antibiotic drugs.
Simple disinfectant use has been shown to reduce rates of infection by antibiotic - resistant bacteria, and yet hospitals in many countries, including the United States, often neglect such basic measures.
«It is incredibly tempting to assume that antibiotics are promoting the spread of resistance by increasing the rate at which bacteria share resistant genes with each other, but our research shows they often aren't.»
Our hospitals could one day be brought to their knees by antibiotic - resistant superbugs — doctors and scientists are seeing the first glimpse of such a world
The same expert committee, chaired by economist Jim O'Neill, formerly of investment bank Goldman Sachs, reported earlier this year that companies are not developing new antibiotics fast enough to keep up with the rate at which bacteria are becoming resistant to existing ones.
So much so that a 2014 study commissioned by the Prime Minister of the United Kingdom predicted that, if the problem is left unchecked, in less than 35 years more people will die from antibiotic resistant superbugs than from cancer.
«We showed at the single - cell level that the exchange of resistant genes is not influenced by antibiotics at all, which is in contrast to the literature.»
a b c d e f g h i j k l m n o p q r s t u v w x y z